Terms: = Leukemia AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Treatment
165 results:
1. Earlier intrathecal dexamethasone effectively alleviate immune effector cell-associated neurotoxicity syndrome.
Ji Q; Dong Y; Zhang Y; Wu X; Bai Z; Huang S; Dong X; Wang Y; Pan J; Lu J; Hu S; Wu S
Int Immunopharmacol; 2024 Dec; 142(Pt B):113214. PubMed ID: 39321707
[TBL] [Abstract] [Full Text] [Related]
2. The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia.
Márton A; Veres KB; Erdődi F; Udvardy M; Illés Á; Rejtő L
Pathol Oncol Res; 2024; 30():1611747. PubMed ID: 39035053
[TBL] [Abstract] [Full Text] [Related]
3. Regulation of Cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P Cells.
Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
[TBL] [Abstract] [Full Text] [Related]
4. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
[TBL] [Abstract] [Full Text] [Related]
5. Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcoma.
Lorenzi L; Haferlach T; Mori L; Simbeni M; Walter W; Balzarini P; Meggendorfer M; Döring C; Lonardi S; Bugatti M; Agostinelli C; Mehta J; Borges A; Agaimy A; Simonitsch-Klupp I; Cabeçadas J; Campo E; Pileri SA; Facchetti F; Leo Hansmann M; Hartmann S
Haematologica; 2024 Jun; 109(6):1815-1824. PubMed ID: 37994105
[TBL] [Abstract] [Full Text] [Related]
6. Dasatinib in combination with BMS-754807 induce synergistic cytotoxicity in lung cancer cells through inhibiting lung cancer cell growth, and inducing autophagy as well as cell cycle arrest at the G1 phase.
Zhang C; Zhao X; Wang Z; Gong T; Zhao H; Zhang D; Niu Y; Li X; Zhao X; Li G; Dong X; Zhang L; Liu C; Xu J; Yu B
Invest New Drugs; 2023 Jun; 41(3):438-452. PubMed ID: 37097369
[TBL] [Abstract] [Full Text] [Related]
7. A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia.
Wilde L; Porazzi P; Trotta R; De Dominici M; Palmisiano N; Keiffer G; Rancani K; Yingling K; Calabretta B; Kasner M
Leuk Res; 2023 Jun; 129():107075. PubMed ID: 37079999
[TBL] [Abstract] [Full Text] [Related]
8. Cytotoxic Effects of Darinaparsin, a Novel Organic Arsenical, against Human leukemia Cells.
Yuan B; Kikuchi H; Li J; Kawabata A; Yao K; Takagi N; Okazaki M
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768603
[TBL] [Abstract] [Full Text] [Related]
9. Targeted treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic leukemia.
Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
[TBL] [Abstract] [Full Text] [Related]
10. Predictive role of NKCD56bright cells in monitoring the progression of chronic lymphocytic leukemia during treatment.
Blachnio K; Grygalewicz B; Woroniecka R; Rygier J; Pienkowska-Grela B; Rymkiewicz G; Kawiak J
Folia Histochem Cytobiol; 2022; 60(3):203-214. PubMed ID: 36045602
[TBL] [Abstract] [Full Text] [Related]
11. New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology.
Balducci L; Falandry C; List A
Curr Oncol Rep; 2022 Dec; 24(12):1695-1703. PubMed ID: 35986858
[TBL] [Abstract] [Full Text] [Related]
12. ATPR regulates human mantle cell lymphoma cells differentiation via SOX11/CyclinD1/Rb/E2F1.
Xu X; Zhang T; Zhang M; Li L; Deng G; Lu Z; Zhang Z; Du Y; Feng Y; Feng X; Peng X; Chen F
Cell Signal; 2022 May; 93():110280. PubMed ID: 35151831
[TBL] [Abstract] [Full Text] [Related]
13. Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms.
Balasubramanian SK; Azmi AS; Maciejewski J
Leukemia; 2022 Mar; 36(3):601-612. PubMed ID: 35091658
[TBL] [Abstract] [Full Text] [Related]
14. Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.
Adamia S; Bhatt S; Wen K; Chyra Z; Fell GG; Tai YT; Pioso MS; Abiatari I; Letai A; Dorfman DM; Hideshima T; Anderson KC
Leukemia; 2022 Apr; 36(4):1088-1101. PubMed ID: 35082402
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical analysis of fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of 43 cases of chronic lymphoblastic leukemia].
Wang TY; Yi SH; Wang Y; Lyu R; Wang Q; Deng SH; Sui WW; Fu MW; Huang WY; Liu W; An G; Zhao YZ; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):543-548. PubMed ID: 34455740
[No Abstract] [Full Text] [Related]
16. Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia.
Costa D; Granada I; Espinet B; Collado R; Ruiz-Xivillé N; Puiggros A; Uribe M; Arias A; Gómez C; Delgado J; Pereira A; Magnano L; Colomer D; López C; Beà S
Genes Chromosomes Cancer; 2022 Jan; 61(1):37-43. PubMed ID: 34414624
[TBL] [Abstract] [Full Text] [Related]
17. Proposal and clinical application of molecular genetic risk scoring system, "MRplus", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre.
Gupta SK; Bakhshi S; Kamal VK; Gupta R; Sharma P; Pushpam D; Sahoo RK; Sharma A
Leuk Res; 2021 Dec; 111():106683. PubMed ID: 34371436
[TBL] [Abstract] [Full Text] [Related]
18. Pancracine, a Montanine-Type Amaryllidaceae Alkaloid, Inhibits Proliferation of A549 Lung Adenocarcinoma Cells and Induces Apoptotic Cell Death in MOLT-4 Leukemic Cells.
Koutová D; Havelek R; Peterová E; Muthná D; Královec K; Breiterová K; Cahlíková L; Řezáčová M
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209868
[TBL] [Abstract] [Full Text] [Related]
19. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway.
Bao XY; Sun M; Peng TT; Han DM
Cancer Biomark; 2021; 31(4):307-315. PubMed ID: 33896816
[TBL] [Abstract] [Full Text] [Related]
20. An unknown chromosomal aberration in a patient with chronic lymphocytic leukemia: Extra isochromosome 4q.
Atli EI; Gurkan H; Demir AM
J Cancer Res Ther; 2021; 17(1):282-287. PubMed ID: 33723172
[TBL] [Abstract] [Full Text] [Related]
[Next]